126
Participants
Start Date
September 30, 2024
Primary Completion Date
September 30, 2027
Study Completion Date
September 30, 2027
Selinexor
Selinexor: 60 mg/day from days -9 to -5.
Melphalan
Selinexor: 60 mg/day from days -9 to -5.
Intravenous Busulfan
3.2 mg/kg on days
Fludarabine
30 mg/m² on days
Zhengzhou University First Affiliated Hospital, Zhengzhou
People's Liberation Army The General Hospital of Western Theater Command, Chengdu
Hebei Medical University Second Hospital, Shijiazhuang
The 960th Hospital of the Joint Service Support Force of the Chinese People's Liberation Army, Jinan
Institute of Hematology & Blood Diseases Hospital, China
OTHER